Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer.
about
Functions and mechanisms of long noncoding RNAs in lung cancerFunctions of lncRNA HOTAIR in lung cancerPD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined SubgroupsClinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification.Prognostic value of Bcl-2 expression in patients with non-small-cell lung cancer: a meta-analysis and systemic reviewMicroRNA 192 regulates chemo-resistance of lung adenocarcinoma for gemcitabine and cisplatin combined therapy by targeting Bcl-2.Downregulation of the long non-coding RNA TUSC7 promotes NSCLC cell proliferation and correlates with poor prognosisHigh expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.MALAT1 in Human Adipose Stem Cells Modulates Survival and Alternative Splicing of PKCδII in HT22 Cells.IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth.The Long Noncoding RNA MALAT-1 is A Novel Biomarker in Various Cancers: A Meta-analysis Based on the GEO Database and Literature.Long non-coding RNAs associated with non-small cell lung cancer.HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a.MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer.Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications.Deciphering the roles of lncRNAs in breast development and disease.Expression of metastasis-associated lung adenocarcinoma transcript 1 long non-coding RNA in vitro and in patients with non-small cell lung cancer.MALAT1: A long non-coding RNA highly associated with human cancers.
P2860
Q26738672-0E0BDD99-63E0-49FE-8F61-26631FCD345DQ26849432-2A44B04A-42A9-4CDC-9A66-F4F2B82DBF24Q27853205-1834AC50-318B-4BFC-A8DD-D830EDC27D3EQ33912058-347FAD9C-A3DF-436C-968B-20DF5973F343Q35851986-E45DD88E-5E4B-4EAA-A6AB-2C99DAB624F5Q36182712-016A505C-5089-4B62-8A1D-7B96057D7ED9Q36841220-3CC06AB2-280F-465D-A591-623A29074811Q38729414-FC647C84-84B4-44FA-A70A-6290B64536ACQ38731141-7377AEFC-EC1F-462B-BE16-7F7809683308Q38873952-4C2395AE-0544-4B7D-A0E1-7D4D401DA3CBQ39676060-F34834E8-C950-4091-B6FD-5E4719E22555Q42366666-CC630CE7-65F9-4C30-804D-925AF03D2D55Q42370600-DEA06054-29EE-4EC4-BD98-22CA6064A37DQ50354652-FFD15FF0-5A8F-47DD-B1F5-B3DA927FAA8CQ53048458-0B7745B6-AE8F-4EB4-A0C7-9BD993E7A415Q54975879-73AC4080-C65F-4F19-BE36-663F4B0290A7Q55286324-A8413386-6EC5-4110-A2C0-59C2D4D34763Q55495010-6148C36B-72AB-4D66-AA89-51674C1924F2
P2860
Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Prognostic impact of Bcl-2 dep ...... in non-small-cell lung cancer.
@en
Prognostic impact of Bcl-2 dep ...... in non-small-cell lung cancer.
@nl
type
label
Prognostic impact of Bcl-2 dep ...... in non-small-cell lung cancer.
@en
Prognostic impact of Bcl-2 dep ...... in non-small-cell lung cancer.
@nl
prefLabel
Prognostic impact of Bcl-2 dep ...... in non-small-cell lung cancer.
@en
Prognostic impact of Bcl-2 dep ...... in non-small-cell lung cancer.
@nl
P2093
P1476
Prognostic impact of Bcl-2 dep ...... in non-small-cell lung cancer
@en
P2093
Alessandro Marra
Andreas Faldum
Andreas Huge
Carsten Müller-Tidow
Christian Rohde
Julia Humberg
Lars Henning Schmidt
Martin Schuler
Michael Mohr
Nils H Thoenissen
P304
P356
10.1097/JTO.0000000000000243
P577
2014-09-01T00:00:00Z